nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Dermatitis—Goserelin—breast cancer	0.000841	0.000841	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Capecitabine—breast cancer	0.000839	0.000839	CcSEcCtD
Ceftaroline fosamil—Headache—Goserelin—breast cancer	0.000836	0.000836	CcSEcCtD
Ceftaroline fosamil—Erythema—Docetaxel—breast cancer	0.000835	0.000835	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Docetaxel—breast cancer	0.000835	0.000835	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000833	0.000833	CcSEcCtD
Ceftaroline fosamil—Nausea—Tamoxifen—breast cancer	0.00083	0.00083	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000829	0.000829	CcSEcCtD
Ceftaroline fosamil—Pain—Gemcitabine—breast cancer	0.000822	0.000822	CcSEcCtD
Ceftaroline fosamil—Constipation—Gemcitabine—breast cancer	0.000822	0.000822	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Vinorelbine—breast cancer	0.000818	0.000818	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000815	0.000815	CcSEcCtD
Ceftaroline fosamil—Nausea—Melphalan—breast cancer	0.000813	0.000813	CcSEcCtD
Ceftaroline fosamil—Erythema—Capecitabine—breast cancer	0.000809	0.000809	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Capecitabine—breast cancer	0.000809	0.000809	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Methotrexate—breast cancer	0.000808	0.000808	CcSEcCtD
Ceftaroline fosamil—Pruritus—Thiotepa—breast cancer	0.000808	0.000808	CcSEcCtD
Ceftaroline fosamil—Pain—Fluorouracil—breast cancer	0.000808	0.000808	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Irinotecan—breast cancer	0.000806	0.000806	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000806	0.000806	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Paclitaxel—breast cancer	0.000804	0.000804	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Epirubicin—breast cancer	0.000801	0.000801	CcSEcCtD
Ceftaroline fosamil—Nausea—Goserelin—breast cancer	0.000793	0.000793	CcSEcCtD
Ceftaroline fosamil—Dizziness—Vinorelbine—breast cancer	0.000791	0.000791	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Paclitaxel—breast cancer	0.000789	0.000789	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Doxorubicin—breast cancer	0.000788	0.000788	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Paclitaxel—breast cancer	0.000788	0.000788	CcSEcCtD
Ceftaroline fosamil—Urticaria—Mitoxantrone—breast cancer	0.000783	0.000783	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Thiotepa—breast cancer	0.000781	0.000781	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Paclitaxel—breast cancer	0.000781	0.000781	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Mitoxantrone—breast cancer	0.00078	0.00078	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Mitoxantrone—breast cancer	0.00078	0.00078	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Irinotecan—breast cancer	0.00078	0.00078	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Irinotecan—breast cancer	0.00078	0.00078	CcSEcCtD
Ceftaroline fosamil—Anaemia—Docetaxel—breast cancer	0.000772	0.000772	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Methotrexate—breast cancer	0.00077	0.00077	CcSEcCtD
Ceftaroline fosamil—Infestation—Methotrexate—breast cancer	0.00077	0.00077	CcSEcCtD
Ceftaroline fosamil—Vomiting—Vinorelbine—breast cancer	0.00076	0.00076	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Gemcitabine—breast cancer	0.000759	0.000759	CcSEcCtD
Ceftaroline fosamil—Renal failure—Methotrexate—breast cancer	0.000757	0.000757	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Epirubicin—breast cancer	0.000756	0.000756	CcSEcCtD
Ceftaroline fosamil—Dizziness—Thiotepa—breast cancer	0.000755	0.000755	CcSEcCtD
Ceftaroline fosamil—Rash—Vinorelbine—breast cancer	0.000754	0.000754	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Vinorelbine—breast cancer	0.000753	0.000753	CcSEcCtD
Ceftaroline fosamil—Urticaria—Fluorouracil—breast cancer	0.00075	0.00075	CcSEcCtD
Ceftaroline fosamil—Headache—Vinorelbine—breast cancer	0.000749	0.000749	CcSEcCtD
Ceftaroline fosamil—Anaemia—Capecitabine—breast cancer	0.000748	0.000748	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Fluorouracil—breast cancer	0.000747	0.000747	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Doxorubicin—breast cancer	0.000741	0.000741	CcSEcCtD
Ceftaroline fosamil—Palpitations—Docetaxel—breast cancer	0.000738	0.000738	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Epirubicin—breast cancer	0.000729	0.000729	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Methotrexate—breast cancer	0.000729	0.000729	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Irinotecan—breast cancer	0.000727	0.000727	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Mitoxantrone—breast cancer	0.000727	0.000727	CcSEcCtD
Ceftaroline fosamil—Vomiting—Thiotepa—breast cancer	0.000726	0.000726	CcSEcCtD
Ceftaroline fosamil—Convulsion—Docetaxel—breast cancer	0.000724	0.000724	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Epirubicin—breast cancer	0.000721	0.000721	CcSEcCtD
Ceftaroline fosamil—Infestation—Epirubicin—breast cancer	0.000721	0.000721	CcSEcCtD
Ceftaroline fosamil—Rash—Thiotepa—breast cancer	0.00072	0.00072	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Thiotepa—breast cancer	0.000719	0.000719	CcSEcCtD
Ceftaroline fosamil—Headache—Thiotepa—breast cancer	0.000715	0.000715	CcSEcCtD
Ceftaroline fosamil—Palpitations—Capecitabine—breast cancer	0.000715	0.000715	CcSEcCtD
Ceftaroline fosamil—Nausea—Vinorelbine—breast cancer	0.00071	0.00071	CcSEcCtD
Ceftaroline fosamil—Renal failure—Epirubicin—breast cancer	0.000709	0.000709	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000706	0.000706	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Doxorubicin—breast cancer	0.0007	0.0007	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Fluorouracil—breast cancer	0.000696	0.000696	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000694	0.000694	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Methotrexate—breast cancer	0.000692	0.000692	CcSEcCtD
Ceftaroline fosamil—Pain—Paclitaxel—breast cancer	0.000688	0.000688	CcSEcCtD
Ceftaroline fosamil—Constipation—Paclitaxel—breast cancer	0.000688	0.000688	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000684	0.000684	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Methotrexate—breast cancer	0.000683	0.000683	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Epirubicin—breast cancer	0.000682	0.000682	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Docetaxel—breast cancer	0.000682	0.000682	CcSEcCtD
Ceftaroline fosamil—Pruritus—Gemcitabine—breast cancer	0.00068	0.00068	CcSEcCtD
Ceftaroline fosamil—Nausea—Thiotepa—breast cancer	0.000678	0.000678	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Methotrexate—breast cancer	0.000678	0.000678	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Doxorubicin—breast cancer	0.000675	0.000675	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Irinotecan—breast cancer	0.000675	0.000675	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Mitoxantrone—breast cancer	0.000675	0.000675	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Docetaxel—breast cancer	0.000669	0.000669	CcSEcCtD
Ceftaroline fosamil—Pruritus—Fluorouracil—breast cancer	0.000668	0.000668	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Docetaxel—breast cancer	0.000668	0.000668	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Doxorubicin—breast cancer	0.000667	0.000667	CcSEcCtD
Ceftaroline fosamil—Infestation—Doxorubicin—breast cancer	0.000667	0.000667	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Docetaxel—breast cancer	0.000662	0.000662	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Epirubicin—breast cancer	0.000659	0.000659	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Paclitaxel—breast cancer	0.000658	0.000658	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Gemcitabine—breast cancer	0.000657	0.000657	CcSEcCtD
Ceftaroline fosamil—Renal failure—Doxorubicin—breast cancer	0.000656	0.000656	CcSEcCtD
Ceftaroline fosamil—Dizziness—Irinotecan—breast cancer	0.000652	0.000652	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Capecitabine—breast cancer	0.000647	0.000647	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Epirubicin—breast cancer	0.000647	0.000647	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Fluorouracil—breast cancer	0.000646	0.000646	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Capecitabine—breast cancer	0.000646	0.000646	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Capecitabine—breast cancer	0.000641	0.000641	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Epirubicin—breast cancer	0.000639	0.000639	CcSEcCtD
Ceftaroline fosamil—Urticaria—Paclitaxel—breast cancer	0.000639	0.000639	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Paclitaxel—breast cancer	0.000636	0.000636	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Paclitaxel—breast cancer	0.000636	0.000636	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Epirubicin—breast cancer	0.000634	0.000634	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Doxorubicin—breast cancer	0.000631	0.000631	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Methotrexate—breast cancer	0.000628	0.000628	CcSEcCtD
Ceftaroline fosamil—Vomiting—Irinotecan—breast cancer	0.000627	0.000627	CcSEcCtD
Ceftaroline fosamil—Vomiting—Mitoxantrone—breast cancer	0.000627	0.000627	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Methotrexate—breast cancer	0.000625	0.000625	CcSEcCtD
Ceftaroline fosamil—Dizziness—Fluorouracil—breast cancer	0.000625	0.000625	CcSEcCtD
Ceftaroline fosamil—Rash—Irinotecan—breast cancer	0.000622	0.000622	CcSEcCtD
Ceftaroline fosamil—Rash—Mitoxantrone—breast cancer	0.000622	0.000622	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Irinotecan—breast cancer	0.000621	0.000621	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Mitoxantrone—breast cancer	0.000621	0.000621	CcSEcCtD
Ceftaroline fosamil—Headache—Irinotecan—breast cancer	0.000618	0.000618	CcSEcCtD
Ceftaroline fosamil—Headache—Mitoxantrone—breast cancer	0.000618	0.000618	CcSEcCtD
Ceftaroline fosamil—Vomiting—Gemcitabine—breast cancer	0.000611	0.000611	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Doxorubicin—breast cancer	0.00061	0.00061	CcSEcCtD
Ceftaroline fosamil—Rash—Gemcitabine—breast cancer	0.000606	0.000606	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Gemcitabine—breast cancer	0.000605	0.000605	CcSEcCtD
Ceftaroline fosamil—Erythema—Methotrexate—breast cancer	0.000602	0.000602	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Methotrexate—breast cancer	0.000602	0.000602	CcSEcCtD
Ceftaroline fosamil—Headache—Gemcitabine—breast cancer	0.000602	0.000602	CcSEcCtD
Ceftaroline fosamil—Vomiting—Fluorouracil—breast cancer	0.000601	0.000601	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Doxorubicin—breast cancer	0.000599	0.000599	CcSEcCtD
Ceftaroline fosamil—Rash—Fluorouracil—breast cancer	0.000596	0.000596	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Fluorouracil—breast cancer	0.000595	0.000595	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Paclitaxel—breast cancer	0.000593	0.000593	CcSEcCtD
Ceftaroline fosamil—Headache—Fluorouracil—breast cancer	0.000592	0.000592	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Doxorubicin—breast cancer	0.000591	0.000591	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Docetaxel—breast cancer	0.000589	0.000589	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Epirubicin—breast cancer	0.000587	0.000587	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Doxorubicin—breast cancer	0.000587	0.000587	CcSEcCtD
Ceftaroline fosamil—Nausea—Irinotecan—breast cancer	0.000586	0.000586	CcSEcCtD
Ceftaroline fosamil—Nausea—Mitoxantrone—breast cancer	0.000586	0.000586	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Epirubicin—breast cancer	0.000585	0.000585	CcSEcCtD
Ceftaroline fosamil—Pain—Docetaxel—breast cancer	0.000583	0.000583	CcSEcCtD
Ceftaroline fosamil—Constipation—Docetaxel—breast cancer	0.000583	0.000583	CcSEcCtD
Ceftaroline fosamil—Nausea—Gemcitabine—breast cancer	0.000571	0.000571	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Capecitabine—breast cancer	0.00057	0.00057	CcSEcCtD
Ceftaroline fosamil—Pruritus—Paclitaxel—breast cancer	0.000569	0.000569	CcSEcCtD
Ceftaroline fosamil—Pain—Capecitabine—breast cancer	0.000564	0.000564	CcSEcCtD
Ceftaroline fosamil—Constipation—Capecitabine—breast cancer	0.000564	0.000564	CcSEcCtD
Ceftaroline fosamil—Erythema—Epirubicin—breast cancer	0.000563	0.000563	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Epirubicin—breast cancer	0.000563	0.000563	CcSEcCtD
Ceftaroline fosamil—Nausea—Fluorouracil—breast cancer	0.000561	0.000561	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Docetaxel—breast cancer	0.000557	0.000557	CcSEcCtD
Ceftaroline fosamil—Anaemia—Methotrexate—breast cancer	0.000556	0.000556	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Paclitaxel—breast cancer	0.00055	0.00055	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Doxorubicin—breast cancer	0.000543	0.000543	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Doxorubicin—breast cancer	0.000541	0.000541	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Capecitabine—breast cancer	0.00054	0.00054	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Docetaxel—breast cancer	0.000539	0.000539	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Docetaxel—breast cancer	0.000539	0.000539	CcSEcCtD
Ceftaroline fosamil—Dizziness—Paclitaxel—breast cancer	0.000532	0.000532	CcSEcCtD
Ceftaroline fosamil—Urticaria—Capecitabine—breast cancer	0.000524	0.000524	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Capecitabine—breast cancer	0.000522	0.000522	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Capecitabine—breast cancer	0.000522	0.000522	CcSEcCtD
Ceftaroline fosamil—Convulsion—Methotrexate—breast cancer	0.000522	0.000522	CcSEcCtD
Ceftaroline fosamil—Erythema—Doxorubicin—breast cancer	0.000521	0.000521	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Doxorubicin—breast cancer	0.000521	0.000521	CcSEcCtD
Ceftaroline fosamil—Anaemia—Epirubicin—breast cancer	0.000521	0.000521	CcSEcCtD
Ceftaroline fosamil—Vomiting—Paclitaxel—breast cancer	0.000511	0.000511	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000509	0.000509	CcSEcCtD
Ceftaroline fosamil—Rash—Paclitaxel—breast cancer	0.000507	0.000507	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Paclitaxel—breast cancer	0.000507	0.000507	CcSEcCtD
Ceftaroline fosamil—Headache—Paclitaxel—breast cancer	0.000504	0.000504	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Docetaxel—breast cancer	0.000502	0.000502	CcSEcCtD
Ceftaroline fosamil—Palpitations—Epirubicin—breast cancer	0.000498	0.000498	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Methotrexate—breast cancer	0.000491	0.000491	CcSEcCtD
Ceftaroline fosamil—Convulsion—Epirubicin—breast cancer	0.000488	0.000488	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Capecitabine—breast cancer	0.000486	0.000486	CcSEcCtD
Ceftaroline fosamil—Pruritus—Docetaxel—breast cancer	0.000482	0.000482	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Methotrexate—breast cancer	0.000482	0.000482	CcSEcCtD
Ceftaroline fosamil—Anaemia—Doxorubicin—breast cancer	0.000482	0.000482	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Methotrexate—breast cancer	0.000481	0.000481	CcSEcCtD
Ceftaroline fosamil—Nausea—Paclitaxel—breast cancer	0.000478	0.000478	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Methotrexate—breast cancer	0.000477	0.000477	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000476	0.000476	CcSEcCtD
Ceftaroline fosamil—Pruritus—Capecitabine—breast cancer	0.000467	0.000467	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Docetaxel—breast cancer	0.000466	0.000466	CcSEcCtD
Ceftaroline fosamil—Palpitations—Doxorubicin—breast cancer	0.000461	0.000461	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Epirubicin—breast cancer	0.00046	0.00046	CcSEcCtD
Ceftaroline fosamil—Convulsion—Doxorubicin—breast cancer	0.000452	0.000452	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Capecitabine—breast cancer	0.000452	0.000452	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Epirubicin—breast cancer	0.000451	0.000451	CcSEcCtD
Ceftaroline fosamil—Dizziness—Docetaxel—breast cancer	0.000451	0.000451	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Epirubicin—breast cancer	0.00045	0.00045	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Epirubicin—breast cancer	0.000447	0.000447	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000441	0.000441	CcSEcCtD
Ceftaroline fosamil—Dizziness—Capecitabine—breast cancer	0.000436	0.000436	CcSEcCtD
Ceftaroline fosamil—Vomiting—Docetaxel—breast cancer	0.000433	0.000433	CcSEcCtD
Ceftaroline fosamil—Rash—Docetaxel—breast cancer	0.00043	0.00043	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Docetaxel—breast cancer	0.000429	0.000429	CcSEcCtD
Ceftaroline fosamil—Headache—Docetaxel—breast cancer	0.000427	0.000427	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Doxorubicin—breast cancer	0.000425	0.000425	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Methotrexate—breast cancer	0.000424	0.000424	CcSEcCtD
Ceftaroline fosamil—Pain—Methotrexate—breast cancer	0.00042	0.00042	CcSEcCtD
Ceftaroline fosamil—Vomiting—Capecitabine—breast cancer	0.00042	0.00042	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Doxorubicin—breast cancer	0.000417	0.000417	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Doxorubicin—breast cancer	0.000417	0.000417	CcSEcCtD
Ceftaroline fosamil—Rash—Capecitabine—breast cancer	0.000416	0.000416	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Capecitabine—breast cancer	0.000416	0.000416	CcSEcCtD
Ceftaroline fosamil—Headache—Capecitabine—breast cancer	0.000414	0.000414	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Doxorubicin—breast cancer	0.000413	0.000413	CcSEcCtD
Ceftaroline fosamil—Nausea—Docetaxel—breast cancer	0.000405	0.000405	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Methotrexate—breast cancer	0.000402	0.000402	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Epirubicin—breast cancer	0.000397	0.000397	CcSEcCtD
Ceftaroline fosamil—Pain—Epirubicin—breast cancer	0.000393	0.000393	CcSEcCtD
Ceftaroline fosamil—Constipation—Epirubicin—breast cancer	0.000393	0.000393	CcSEcCtD
Ceftaroline fosamil—Nausea—Capecitabine—breast cancer	0.000392	0.000392	CcSEcCtD
Ceftaroline fosamil—Urticaria—Methotrexate—breast cancer	0.00039	0.00039	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Methotrexate—breast cancer	0.000388	0.000388	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Methotrexate—breast cancer	0.000388	0.000388	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Epirubicin—breast cancer	0.000376	0.000376	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000367	0.000367	CcSEcCtD
Ceftaroline fosamil—Urticaria—Epirubicin—breast cancer	0.000365	0.000365	CcSEcCtD
Ceftaroline fosamil—Constipation—Doxorubicin—breast cancer	0.000364	0.000364	CcSEcCtD
Ceftaroline fosamil—Pain—Doxorubicin—breast cancer	0.000364	0.000364	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Epirubicin—breast cancer	0.000364	0.000364	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Epirubicin—breast cancer	0.000364	0.000364	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Methotrexate—breast cancer	0.000362	0.000362	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Doxorubicin—breast cancer	0.000348	0.000348	CcSEcCtD
Ceftaroline fosamil—Pruritus—Methotrexate—breast cancer	0.000348	0.000348	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Epirubicin—breast cancer	0.000339	0.000339	CcSEcCtD
Ceftaroline fosamil—Urticaria—Doxorubicin—breast cancer	0.000338	0.000338	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Doxorubicin—breast cancer	0.000336	0.000336	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Doxorubicin—breast cancer	0.000336	0.000336	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Methotrexate—breast cancer	0.000336	0.000336	CcSEcCtD
Ceftaroline fosamil—Pruritus—Epirubicin—breast cancer	0.000325	0.000325	CcSEcCtD
Ceftaroline fosamil—Dizziness—Methotrexate—breast cancer	0.000325	0.000325	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Epirubicin—breast cancer	0.000315	0.000315	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Doxorubicin—breast cancer	0.000313	0.000313	CcSEcCtD
Ceftaroline fosamil—Vomiting—Methotrexate—breast cancer	0.000312	0.000312	CcSEcCtD
Ceftaroline fosamil—Rash—Methotrexate—breast cancer	0.00031	0.00031	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Methotrexate—breast cancer	0.00031	0.00031	CcSEcCtD
Ceftaroline fosamil—Headache—Methotrexate—breast cancer	0.000308	0.000308	CcSEcCtD
Ceftaroline fosamil—Dizziness—Epirubicin—breast cancer	0.000304	0.000304	CcSEcCtD
Ceftaroline fosamil—Pruritus—Doxorubicin—breast cancer	0.000301	0.000301	CcSEcCtD
Ceftaroline fosamil—Vomiting—Epirubicin—breast cancer	0.000292	0.000292	CcSEcCtD
Ceftaroline fosamil—Nausea—Methotrexate—breast cancer	0.000292	0.000292	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Doxorubicin—breast cancer	0.000291	0.000291	CcSEcCtD
Ceftaroline fosamil—Rash—Epirubicin—breast cancer	0.00029	0.00029	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Epirubicin—breast cancer	0.00029	0.00029	CcSEcCtD
Ceftaroline fosamil—Headache—Epirubicin—breast cancer	0.000288	0.000288	CcSEcCtD
Ceftaroline fosamil—Dizziness—Doxorubicin—breast cancer	0.000281	0.000281	CcSEcCtD
Ceftaroline fosamil—Nausea—Epirubicin—breast cancer	0.000273	0.000273	CcSEcCtD
Ceftaroline fosamil—Vomiting—Doxorubicin—breast cancer	0.000271	0.000271	CcSEcCtD
Ceftaroline fosamil—Rash—Doxorubicin—breast cancer	0.000268	0.000268	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Doxorubicin—breast cancer	0.000268	0.000268	CcSEcCtD
Ceftaroline fosamil—Headache—Doxorubicin—breast cancer	0.000267	0.000267	CcSEcCtD
Ceftaroline fosamil—Nausea—Doxorubicin—breast cancer	0.000253	0.000253	CcSEcCtD
